CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive income (loss)	Accumulated deficit
Beginning Balance (in shares) at Nov. 30, 2020		38,864,872
Beginning Balance at Nov. 30, 2020	$ 290,269	$ 39	$ 393,841	$ 87	$ (103,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		5,175,000
Issuance of common stock	150,157	$ 5	150,152
Exercise of stock options (in shares)		522,006
Exercise of stock options	1,666	$ 1	1,665
Repurchase of unvested early exercised stock options (in shares)		(971)
Repurchase of unvested early exercised stock options	0
Vesting of early exercised stock options	239		239
Issuance under employee stock purchase plan (in shares)		103,464
Issuance under employee stock purchase plan	2,060		2,060
Stock-based compensation	15,800		15,800
Unrealized loss on available-for-sale marketable securities	(695)			(695)
Net loss	(117,194)				(117,194)
Ending Balance (in shares) at Nov. 30, 2021		44,664,371
Ending Balance at Nov. 30, 2021	342,302	$ 45	563,757	(608)	(220,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		2,000,000
Issuance of common stock	19,328	$ 2	19,326
Issuance of pre-funded warrants, net of issuance costs of $234	94,759		94,759
Exercise of stock options (in shares)		325,596
Exercise of stock options	1,078		1,078
Vesting of restricted stock units (in shares)		46,028
Vesting of restricted stock units	0
Vesting of early exercised stock options	145		145
Issuance under employee stock purchase plan (in shares)		136,304
Issuance under employee stock purchase plan	1,955		1,955
Stock-based compensation	28,200		28,200
Unrealized loss on available-for-sale marketable securities	(3,711)			(3,711)
Net loss	(180,360)				(180,360)
Ending Balance (in shares) at Nov. 30, 2022		47,172,299
Ending Balance at Nov. 30, 2022	$ 303,696	$ 47	$ 709,220	$ (4,319)	$ (401,252)